Intertek Pharmaceutical Services

Case Study | Particulate Matter in an Injectable Drug Product 📝 Particulate contamination is a critical quality attribute for any pharmaceutical. In this case study, our expert, Dr Peter Muehlschlegel describes the steps of an investigation into the occurrence of foreign particulate matter (FPM) in a lyophilised drug product. The composition of FPM was identified through the application of microscopy and spectroscopy techniques which helped to confirm the origin of the particles. The insight from this study then helped to de-risk the production process in relation to FPM. Get the full insights by downloading the case study and improve your pharmaceutical product safety strategies: https://lnkd.in/eTumyfkT #DrugSafety #QualityControl #ParticulateMatter #InjectableDrugs #Intertek

The #mRNA therapies revolution continues to evolve, offering the potential to accelerate the development of new vaccines and therapeutics. If you’re involved in mRNA product development, expert mRNA characterization and analysis support are essential for navigating the challenges of development and authorization. For nearly three decades, we’ve assisted the world’s most innovative bio/pharmaceutical companies in overcoming challenges related to new product and vaccine development, drug delivery, production, and market release. Explore our specialized expertise in mRNA characterization, GMP analysis, and quality control testing. For more details, please see our brochure below. ⬇️ #mRNATherapies #DrugDevelopment #vaccines #Intertek

✨ What an incredible event! Our team is thrilled to be in Boston this week. Don't hesitate to contact Lucy B. or Cameron May to learn more about how we can help with your #gene therapy projects. Thank you for the warm greetings and engaging conversations. It's these interactions that make events like #GTAD so special. If you missed joining us for our talk at the Gene Therapy Analytical Development & CMC Summit, you could request our presentation and discover more about the innovative application of Next-Generation Sequencing (NGS) in genome analysis and regulatory frameworks. 👉 Request a copy of our slides here: https://lnkd.in/d6kVChuv #GeneTherapy #NextGenerationSequencing #Pharma #CMC

We are pleased to announce that our Bioanalytical Technical Expert, Deborah McManus, will present at the 11th EBF Open Symposium in Barcelona. Her presentation, titled “Recombinant Biomarkers: Are They Fit-for-Purpose for Every Context of Use?” promises to be insightful and thought-provoking. Not attending? You can request a copy: bioanalysis@intertek.com Our expert team eagerly looks forward to the event (20-22 Nov), fully prepared to delve into your bioanalytical challenges and demonstrate our cutting-edge solutions. If you are attending, we would be delighted to arrange a meeting. Please reach out to Mairita Ntoulovi, Samuel Kirkwood, or Matthew Dennen for more information, or visit our exhibition stand. With over 30 years of experience, our bioanalysis expertise provides a single-source solution for both small molecules and biologics. Our experienced scientists and regulatory experts work closely with you to ensure your timelines are met, and the value of your programs is optimized. #Bioanalysis #DrugDevelopment #EBFOpenSymposium #EBFBarcelona #Intertek

👨🔬 Today, Marcin Fraczek, PhD, Senior Scientist at Intertek, presented “Harnessing the Power of Next-Generation Sequencing (NGS): Applications in the Development of Gene Therapies” at the Gene Therapy Analytical Development & CMC Summit in Boston. The session covered groundbreaking NGS applications in genome analysis, regulatory frameworks, and highlighted the Illumina MiSeq platform’s transformative impact on research and industry. Get all the insights! 👉 Request a copy of our slides here: https://lnkd.in/d6kVChuv #GTAD #GeneTherapy #NextGenerationSequencing #Pharma #CMC

🙌 The Gene Therapy Analytical Development & CMC Summit Boston is in full swing! We look forward to sharing our advanced gene therapy characterization and release testing services and expertise with you! Stop by our stand or schedule a meeting to discuss your gene therapy development programs. We can help you unlock your gene therapy product's potential and guarantee its safety, quality, and potency. From early-stage development through GMP release, we provide method development, validation, and total quality assurance to ensure your gene therapy product meets all regulatory requirements. Reach out to Lucy B. and Cameron May to find out more. 🎤 Join us today at 12:30 pm for our presentation, "Harnessing the Power of Next-Generation Sequencing (NGS): Applications in the Development of Gene Therapies." Led by Marcin Fraczek, PhD., Senior Scientist at Intertek, this session will explore innovative NGS applications in genome analysis and regulatory frameworks.    If you’re interested in discussing the versatile Illumina MiSeq platform and its impact on research and industry, feel free to request a copy of our slides. 👉 Request a copy of our slides here: https://lnkd.in/d6kVChuv #GTAD #GeneTherapy #NextGenerationSequencing #Pharma #CMC

Happy #Halloween from Intertek Pharma! Today, we are delighted to share some special treats with you. 🍬 Recently our UK teams participated in a photography challenge. We are excited to present a collection of stunning photos that perfectly capture Halloween's enchanting essence. Our team's boundless creativity is evident in these remarkable works, ranging from ghostly apparitions to wise owls. We hope these images inspire your own Halloween celebrations. 🎃 #Halloween2024 #Intertek #Pharma #IntertekInspiration

🚀 We are buzzing with excitement! Meet our team of experts this week at the 6th Gene Therapy Analytical Development & CMC Summit (Oct 30-Nov 1, Boston) to discuss your gene therapy characterization and release testing challenges. Reach out to Lucy B. and Cameron May to learn more. Let us help you navigate the complexities of your gene therapy product development with our powerful, advanced analytical tools and expertise. 🎤 We invite you to join us for our event talk tomorrow at 12:30 PM on “Harnessing the Power of Next-Generation Sequencing (NGS): Applications in the Development of Gene Therapies”. Our expert, Marcin Fraczek, PhD, Senior Scientist at Intertek, will explore the innovative application of NGS in genome analysis and regulatory frameworks. He will discuss the versatile Illumina MiSeq platform and its impactful role in research and industry. Don't miss this insightful session! 👉 You can request a copy of our presentation here: https://lnkd.in/d6kVChuv #GTAD #GeneTherapy #NextGenerationSequencing #Pharma

We are excited to announce our technical poster presentation at the 2nd LNP Characterization & Analytical Development Summit (Boston, MA). Our Technical Expert, Dr Tharshini Vinayahan, will present on “Orthogonal Characterization of Nano Delivery Systems for New Drug Applications and In-vitro Bioequivalence Abbreviated New Drug Applications,” which promises to be inspiring and insightful. Unable to attend the event? Request your copy of the poster presentation. We will be pleased to share it with you after the event: https://lnkd.in/ewagQc_W Join us at the LNP event (Nov 6-8, 2024) to discuss enhancing your LNP characterization and analytical methods across pipeline development. Gain deeper insights into LNP structure, ensure stability and integrity, and bolster confidence in regulatory submissions. For more details, please get in touch with Diogo Rodrigues. #LipidNanoparticle #LNPs #LNPCharacterization #LNPAnalysis #Intertek